VC
SVRA icon

VarCov Co’s Savara SVRA Stock Holding History

VarCov Co’s Portfolio SVRA Stock Details SVRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-48,335
Closed -$264K – 545
2026
Q1 		$264K Buy
+48,335
New +$269K 0.1% 302

Other funds holding SVRA

NMC
NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.68B AUM 126.09% 1-Year Est. Return
VA
VR Adviser New York $3.3B AUM 525.74% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return
PCH
Polar Capital Holdings London, United Kingdom $42.4B AUM 181.11% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return

VarCov Co's SVRA Position: Q2 2026 in Review

VarCov Co sold out of Savara (SVRA) in Q2 2026, closing a stake of 48,335 shares — an estimated $264K sold.

VarCov Co first reported a position in SVRA in Q1 2026 and held it in 1 quarter. The position peaked at $264K in Q1 2026. 179 funds tracked by Wall St. Rank hold SVRA as of Q2 2026.

  • VarCov Co reported no remaining Savara position as of Q2 2026 after selling out during the quarter.
  • VarCov Co sold 48,335 Savara shares in Q2 2026, an estimated $264K.
  • VarCov Co first reported a position in Savara in Q1 2026 and held it in 1 quarter.
  • VarCov Co's Savara position peaked at $264K in Q1 2026.
  • 179 funds tracked by Wall St. Rank held Savara as of Q2 2026.

Based on VarCov Co's 13F filing for Q2 2026, filed 14 Aug 2026.